Topic
chemotherapy
44 stories related to this topic, newest first.
Statscience2 days ago
Johnson & Johnson Reports Second-Quarter Earnings Alongside Biotech Study Results
Johnson & Johnson released its second-quarter results on July 15, 2026. Separate midstage and Phase 3 studies showed progress for an oral minoxidil formulation and a targeted chemotherapy drug.
Newsweekworld12 days ago
Kentucky Infant Diagnosed With Rare Liver Cancer Following Mother's Observations
Hannah Damron noticed a knot and other signs in her daughter Miley shortly after birth. An ultrasound led to a hepatoblastoma diagnosis at Kentucky Children's Hospital. The baby has undergone chemotherapy and faces further treatment.
theepochtimes.compolitics13 days ago
Toronto Woman Cancer-Free After Ovarian-Cancer Surgery at 20 Weeks and Chemotherapy Following Preterm Twin Delivery
Sasha Sabrina Azeez, 31, of Toronto discovered an ovarian cyst during her twin pregnancy in 2024. She underwent surgery at 20 weeks, delivered the twins at 29 weeks, and completed chemotherapy by December 30. Newsweek reported she is now cancer-free with regular monitoring.
Newsweekworld14 days ago
Sydney Girl’s Wilms Tumor Shrinks After Chemotherapy Before Kidney Removal Surgery
Katie Cullen's 4-year-old daughter Ayla received a stage 3 Intermediate Risk Wilms tumor diagnosis in January 2026 following months of symptoms including fatigue, hives, and an abdominal lump. The tumor shrank from 11 to 6 centimeters after chemotherapy before surgery removed her…
espn.comworld17 days ago
Princess of Wales Finishes National Three Peaks Challenge While Recovering from Chemotherapy
Catherine walked 23 miles and climbed more than 10,000 feet across Ben Nevis, Scafell Pike and Snowdon. GB News reported the effort came 18 months after she disclosed chemotherapy treatment.
news.sky.comworld18 days ago
Princess of Wales Completes Three Highest UK Peaks in Under 24 Hours for Cancer Charity
The Princess of Wales climbed the highest mountains in England, Scotland and Wales within a single day. The effort raised funds for a cancer charity nearly two years after she finished chemotherapy.
news.sky.comworld19 days ago
Princess of Wales completes Britain’s three highest peaks in 24 hours for cancer charity
Kate, the Princess of Wales, climbed Scafell Pike, Ben Nevis and Snowdon within a single day. The 44-year-old, who is in remission after chemotherapy, said the effort aimed to highlight holistic care and raise funds for The Royal Marsden Cancer Charity.
SC
globalnews.caworld19 days ago
Tracy Shaw Admitted to A&E After High Temperatures Following Chemotherapy
GB News reported that the 52-year-old former Coronation Street actress was admitted after repeated high temperatures following chemotherapy. She posted from her hospital bed describing delays due to hot weather and conditions during a heatwave.
TechCrunchai20 days ago
Man Uses AI Model to Help Interpret Ambiguous PET Scan After Lymphoma Chemotherapy
A patient diagnosed with rare non-Hodgkin’s lymphoma gathered multiple medical opinions and fed scan data into Claude to resolve an ambiguous final PET result. The model identified thymus rebound with high probability, later confirmed by a fourth doctor.
ESPNsports22 days agoUpdated
Chris Evert Says Ovarian Cancer Has Returned
The 71-year-old announced the recurrence after recent scans. She has completed surgery and will start chemotherapy while stepping back from work for several months.
AB
Newsweekscience26 days ago
Toddler Audrey Scott Diagnosed With High-Risk Infant Metastatic Medulloblastoma After Routine Checkup
Audrey Scott, 2, completed initial treatment including 21 surgeries and 10 chemotherapy rounds. The family now faces an evidence-free zone with no standard pathway forward.
Fox Newsscience34 days ago
Tyler Mane Announces Breast Cancer Diagnosis and Chemotherapy Start
The actor and former wrestler shared his diagnosis in a video to raise awareness about male breast cancer, which accounts for less than 1% of global cases.
forbes.comfinance36 days ago
Targeted Drug Extended Median Survival by About Six Months Versus Chemotherapy in Advanced Triple-Negative Breast Cancer Trial
More than 640 patients received either the antibody-drug conjugate or chemotherapy as first-line treatment. The targeted therapy extended median progression-free survival to nearly 11 months versus just under 6 months with chemotherapy.
technology37 days ago
Breast Cancer Patients Gain Online Followings and Income During Active Treatment, See Declines After Recovery Begins
Sarah Barness and other young survivors documented chemotherapy and surgery on Patreon and Instagram, gaining income and support that declined once visible signs of illness faded.
deadline.comworld38 days ago
Ann Wilson, 75, Discloses 2024 Cancer Diagnosis, Surgery, Chemo and Radiation in First Public Interview
The 75-year-old Heart singer discussed her 2024 diagnosis, chemotherapy, and return to performing in a June 8, 2026 interview with ABC News.
AB
The Independentscience42 days ago
Study identifies lymph node changes linked to breast cancer spread risk
Researchers examined 331 lymph node samples and found structural alterations in a network of cells that appear before visible cancer spread. The changes varied by cancer type, disease extent, and prior chemotherapy, with some patterns tied to better survival and others to worse o…
Substrate placeholder — needs reviewworld44 days ago
Small Phase-2 Trial Finds 85% of Bladder Cancer Patients Cancer-Free at One Year With Added Immunotherapy
A phase-two study found that adding durvalumab to chemotherapy and radiotherapy kept cancer from returning in 46 of 54 patients. The approach may allow some patients to avoid bladder removal surgery.
forbes.comfinance45 days ago
Blood Test Detects Stage 3 Colon Cancer in Asymptomatic Woman Three Years Before Next Scheduled Colonoscopy
Kim Turner, a 61-year-old physician assistant in Alaska, received a positive Shield blood test result in 2025. A follow-up colonoscopy confirmed adenocarcinoma, leading to surgery and chemotherapy.
GB Newsworld46 days ago
Canadian Researcher With Stage Four Cancer Reaches Everest Summit
Dr Shaunna Burke reached the summit at 3 a.m. on May 23 while managing terminal breast cancer and chemotherapy, raising funds for Macmillan Cancer Support.
citizen.co.zaworld47 days ago
Experimental Lung Cancer Drug Cuts Death Risk by 34% in China Trial
An ivonescimab-based therapy from Akeso and Summit Therapeutics lowered death risk by 34% versus standard care in a late-stage Chinese study. Median survival reached 27.9 months compared with 23.7 months for patients on a PD-1 drug plus chemotherapy.
fortune.compolitics47 days ago
Drug Doubles Survival in Metastatic Pancreatic Cancer Trial
An international trial presented Sunday showed daraxonrasib doubled median survival for patients with metastatic pancreatic cancer compared with standard chemotherapy. France has expanded a personalized screening program to eight additional centers.
Science Newsworld47 days ago
Daraxonrasib Extends Median Survival by Six Months vs Chemotherapy in Previously Treated Advanced Pancreatic Cancer
A Phase III trial of 500 patients found the oral drug daraxonrasib extended median survival to 13 months versus less than seven months with chemotherapy. Results were presented May 31, 2026 at ASCO and published the same day in the New England Journal of Medicine.
SK
Science Newsworld46 days agoUpdated
Pill Nearly Doubles Survival Time in Pancreatic Cancer Trial
A once-daily pill nearly doubled average survival for patients with advanced pancreatic cancer in a 500-patient randomized study. Patients on the drug lived 13.2 months on average versus 6.6 months on chemotherapy.
finance47 days ago
Ivonescimab Plus Chemotherapy Extends Median Survival by Four Months vs Tislelizumab in Chinese Lung Cancer Trial
Data released Sunday showed ivonescimab reduced death risk by 34 percent versus a PD-1 drug plus chemotherapy. The results are being presented at the ASCO meeting.
The Guardianscience48 days ago
Amivantamab Shows Tumor Responses in 43 of 102 Patients with Advanced Head and Neck Cancer
An international trial found the Johnson & Johnson drug shrank or eliminated tumors in 43 of 102 patients whose disease had resisted prior chemotherapy and immunotherapy. Results will be presented Sunday at the American Society of Clinical Oncology meeting in Chicago.
Statscience57 days ago
Merck-Kelun Drug Reduced Lung Cancer Progression Risk by 65 Percent in Trial
Phase 3 study results showed that a targeted chemotherapy developed by Kelun-Biotech and licensed to Merck reduced tumor progression risk by 65 percent in patients with advanced non-small cell lung cancer. A preliminary survival benefit was observed but requires longer follow-up…
Fox Newsscience58 days ago
Merck Drug Sac-TMT Meets Survival Goals in Endometrial Cancer Trial
Merck announced Monday that its investigational drug sacituzumab tirumotecan met primary survival endpoints in a Phase 3 trial for advanced or recurrent endometrial cancer. The TroFuse-005 study compared the drug to physician-chosen chemotherapy in 776 patients.
The Sydney Morning Heraldbusiness59 days ago
Amplia Therapeutics Starts Phase 2b Trial of Narmafotinib for Pancreatic Cancer
Amplia Therapeutics has begun a Phase 2b study testing daily dosing of narmafotinib in newly diagnosed pancreatic cancer patients. The trial combines the drug with standard chemotherapy and will initially enroll 12 patients across Australian sites.
quantamagazine.orgscience60 days ago
Study Maps Cell Types in Triple-Negative Breast Cancer Before Chemotherapy
Researchers analyzed pretreatment samples from 101 patients using single-cell and spatial transcriptomics. The work identified four tumor subtypes and eight cellular communities linked to treatment response.
NA
Fox Newsscience63 days ago
Small University of Rochester Trial Finds Modest Cognitive Benefits From Exercise and Ibuprofen During Chemotherapy
A phase 2 trial of 86 cancer patients undergoing chemotherapy showed that a six-week home exercise program produced the clearest gains in attention and cognitive function. Low-dose ibuprofen alone also yielded greater cognitive improvements than placebo. Researchers cautioned tha…
Fox Newstechnology64 days ago
Patient Reports Symptom Improvement in Phase III Trial of Experimental Targeted Chemotherapy for Pancreatic Cancer
Hernando Salcedo, 83, experienced fewer side effects and regained energy after eight TAMP sessions delivered via RenovoRx's RenovoCath device at Miami Cancer Institute. Early TIGeR-PaC trial data showed trends toward better survival and 65% fewer adverse events. Enrollment is exp…
nypost.comworld70 days ago
Former South Carolina Quarterback Stephen Garcia Diagnosed With Stage 4 Colorectal Cancer
Stephen Garcia, 38, who played quarterback for the University of South Carolina from 2008 to 2011, announced his Stage 4 colorectal cancer diagnosis. He first experienced symptoms in July 2025 and began chemotherapy this week. Garcia held a press conference on May 8, 2026, urging…
AB
nypost.comworld71 days ago
Dave Coulier Reveals 45-Pound Weight Loss From Cancer Radiation Treatment
Dave Coulier, 66, said he lost 45 pounds after undergoing extensive radiation for throat cancer and chemotherapy for non-Hodgkin’s lymphoma. In an Instagram Reel posted Thursday, the Full House actor explained he has not eaten solid food in months and that the treatment affected…
The Independentworld71 days ago
Manchester City Forward Misses Title Celebrations Due to Mother's Illness
Vivianne Miedema missed Manchester City's last two Women's Super League matches after her mother experienced serious complications following chemotherapy treatment for cancer. The forward revealed on social media that her mother has been in intensive care and is now in recovery.…
world71 days ago
Refugee in ICE Detention Missed Chemotherapy Sessions While Receiving Treatment for Terminal Cancer
A Laotian refugee who arrived in the United States in the early 1980s missed multiple chemotherapy sessions for terminal Hodgkin’s lymphoma while held in federal immigration detention. The 57-year-old man is now receiving hospice care after the cancer spread to his bone marrow. H…
Nbc Newsscience72 days ago
Experimental Pancreatic Cancer Drug Doubles Survival in Advanced Cases
An experimental drug called daraxonrasib has shown it can double survival time for patients with advanced pancreatic cancer when combined with chemotherapy. The Food and Drug Administration has fast-tracked the drug for approval and allowed expanded access outside clinical trials…
ecns.cnscience84 days ago
Researchers Identify GPX4 Inhibitors That Target Senescent Cells in Cancer Models
A study has identified GPX4 inhibitors that selectively kill senescent cells, which accumulate in tumors after chemotherapy. These compounds showed effectiveness in preclinical models of melanoma, prostate, and ovarian cancer. The findings suggest a potential new strategy for can…
ER
news.google.comscience91 days ago
Revolution Medicines Reports Extended Survival in Pancreatic Cancer Trial
Revolution Medicines announced results from a Phase 3 study of its experimental drug daraxonrasib for advanced pancreatic adenocarcinoma. Patients treated with the drug had a median survival of 13.2 months, compared to 6.7 months for those on standard chemotherapy. The company pl…
ST
Substrate placeholder — needs reviewscience93 days ago
Phase 3 Trial Finds Daraxonrasib Doubles Median Survival to 7 Months in Advanced Pancreatic Cancer
A Phase 3 clinical trial by RevMed found that daraxonrasib extended median overall survival to 13.2 months compared to 6.7 months with standard chemotherapy in patients with metastatic pancreatic ductal adenocarcinoma. Former Sen. Ben Sasse, diagnosed with Stage 4 pancreatic canc…
France 24science93 days ago
Revolution Medicines' Daraxonrasib Trial Reports 13.2-Month Median Survival in Pancreatic Cancer Patients
Revolution Medicines announced results from a late-stage trial of its experimental oral drug daraxonrasib for pancreatic cancer patients. Patients receiving daraxonrasib had a median overall survival of 13.2 months, compared to 6.7 months for those on standard intravenous cytotox…
Substrate placeholder — needs reviewfinance95 days ago
Revolution Medicines' Daraxonrasib Succeeds in Phase 3 Trial for Pancreatic Cancer
Revolution Medicines announced that its targeted pill daraxonrasib met primary and secondary endpoints in a Phase 3 trial for metastatic pancreatic cancer patients. The drug extended median survival to 13.2 months compared to 6.7 months with chemotherapy and reduced the risk of d…
ST
Substrate placeholder — needs reviewfinance95 days ago
Revolution Medicines' Daraxonrasib Succeeds in Phase 3 Pancreatic Cancer Trial
Revolution Medicines announced that its drug daraxonrasib met primary and secondary endpoints in a Phase 3 trial for pancreatic cancer patients whose disease had progressed on prior treatment. The trial showed a median overall survival of 13.2 months for daraxonrasib compared to…
medpagetoday.comscience98 days ago
Recent Developments in CAR-T Therapy for Autoimmunity and GSK's Discontinuation of Leucovorin
Researchers are exploring CAR-T cell therapy's potential in treating autoimmune diseases beyond cancer. GlaxoSmithKline announced it will discontinue leucovorin, a drug used in chemotherapy support. These updates highlight ongoing advancements and changes in the biotechnology sec…
ST
Substrate placeholder — needs reviewworld102 days ago
Brockton Hospital Diverts Ambulances Due to Cybersecurity Incident at Signature Healthcare
Brockton Hospital is diverting ambulances following a cybersecurity incident that affected information systems at its parent company, Signature Healthcare. The hospital has canceled chemotherapy appointments scheduled for Tuesday and closed retail pharmacies in Brockton and East…